Fleyfel, M <br/><br/>
Recombinant tissue type plasminogen activator treatment of thrombosed mitral valve prosthesis during pregnancy.  [electronic resource] 

 -  Canadian journal of anaesthesia = Journal canadien d'anesthesie  Jul 1997 
 - 735-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0832-610X 
<br/><br/><label>Standard No.: </label>10.1007/BF03013388  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acenocoumarol--administration & dosage<br/>Adult<br/>Anticoagulants--administration & dosage<br/>Female<br/>Heart Valve Prosthesis--adverse effects<br/>Heparin--administration & dosage<br/>Humans<br/>Mitral Valve<br/>Mitral Valve Insufficiency--etiology<br/>Plasminogen Activators--therapeutic use<br/>Pregnancy<br/>Pregnancy Complications, Cardiovascular--drug therapy<br/>Pregnancy Outcome<br/>Recombinant Proteins--therapeutic use<br/>Thrombolytic Therapy<br/>Thrombosis--drug therapy<br/>Tissue Plasminogen Activator--therapeutic use